Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals

American Journal of Medicine

Volumn 100, Issue 4, 1996, Pages 386-394

  Hartert, Tina V ^a,d   Windom, Hugh H ^a,b   Peebles Jr , R Stokes ^a,b,d   Freidhoff, Linda R ^a,b   Togias, Alkis ^a,b,c,e  

^a Department of Medicine ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Pulmonary and Critical Care Medicine   (United States)

^d Department of Medicine   (United States)

^e JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; THEOPHYLLINE DERIVATIVE;

AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; DISEASE SEVERITY; EMERGENCY TREATMENT; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MORBIDITY; NEBULIZER; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RISK FACTOR; SMOKING HABIT;

EID: 0029868415     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)89513-7     Document Type: Article

References (31)

1. Evans R, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US. Prevalance, hospitalization and death from asthma over two decades: 1965-1984. Chest. 1987;91:65S-74S.
2. Asthma - United States, 1980-1987. MMWR. 1990;39:493-497.
3. Weiss KB, Wagener DK. Changing patterns of asthma mortality identifying target populations at high risk. JAMA. 1990;264:1683-1687.
4. Weiss KB, Gergen PJ, Crain EF. Inner-city asthma. The epidemiology of an emerging US public health concern. Chest. 1992;101(suppl):362S-367S.
5. Carr W, Zeitel L. Asthma hospitalization and mortality in New York City. Am J Pub Health. 1992;82:59-65.
6. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the U.S. population by social and environmental factors: data from the second national health and nutrition examination survey, 1976 (NHANES II). Ann Allergy. 1991;67:147-154.
7. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. NEJM. 1994;331:1542-1546.
8. Schenker MB, Samet JM, Speizer FE. Risk factors for childhood respiratory disease. Am Rev Respir Dis. 1983;128:1038-1043.
9. Kang B, Vellody D, Homburger H, Yunginger JW. Cockroach cause of allergic asthma. J Allergy Clin Immunol. 1979:63:80-86.
10. Platts-Mills TA, Thomas WR, Aalberse RC, et al. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol. 1992;89:1046-1060.
11. Strunk RC, Mrazek DA, Wolfson-Fuhrman GS. Physiologic and psychologic characteristics associated with deaths due to asthma in childhood. JAMA. 1985;254:1193-1198.
12. Dekker C, Dales R, Bartlett S, et al. Childhood asthma and the indoor environment. Chest. 1991;100:922-926.
13. Hayward RA, Bernard AM, Freeman HE, Corey CR. Regular source of ambulatory care and access to health services. Am J Pub Health. 1991;81:434-438.
14. Donnelly JE, Donnelly WJ, Thong YH. Inadequate parental understanding of asthma medications. Ann Allergy. 1989;62:337-341.
15. Birkhead GB, Attaway NJ, Strunk RC, et al. Investigation of a cluster of deaths of adolescents from asthma: evidence implicating inadequate treatment and poor patient adherence with medications. J Allergy Clin Immunol. 1989;84:484-491.
16. Bailey WC, Richards JM, Brooks CM, et al. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med 1990;150: 1664-1668.
17. Miller TP, Greenberger PA, Patterson R. The diagnosis of potentially fatal asthma in hospitalized adults. Patient characteristics and increased severity of asthma. Chest. 1992;102:515-518.
18. Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md.: U.S. Department of Health and Human Services, DHHS Publication No 91-3042, 1991. (Program NAE, ed.)
19. Windom HH, Burgess CD, Crane J, et al. The self-administration of inhaled beta agonist drugs during severe asthma. NZ Med J. 1990;103:205-207.
20. Cockcroft DW. Cigarette smoking, airway hyperresponsiveness, and asthma. Chest. 1988;94:675-676. Editorial.
21. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. NEJM. 1990;323:1033-1039.
22. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989;139:806-517.
23. Kaliner M. Inhaled corticosteroids for chronic asthma. Am Fam Phys. 1990;42:1609-1616.
24. Friedman RA. Acute and chronic asthma: a stepped therapy approach. J Respir Dis. 1988;9(suppl):S31-S36.
25. Sears MR. Is the routine use of inhaled ß-adrenergic agonists appropriate in asthma treatment? NO. Am J Respir Crit Care Med. 1995;151:600-601.
26. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol. 1995;95:641-651.
27. Shim C, Williams H. Beta agonist aerosol: a major contributor to the delay in care for asthma exacerbation. Am Rev Respir Dis. 1993;147:A773. Abstract.
28. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. NEJM. 1992;326:862-866.
29. Rea HH, Scragg R, Jackson R, et al. A case-control study of deaths from asthma. Thorax. 1986;41:833-839.
30. Cockcroft DW. Beta-agonists, airway hyperresponsiveness, and asthma. J Allergy Clin Immunol. 1992;90:739-741.
31. Burrows B, Lebowitz MD. The ß-agonist dilemma. NEJM. 1992;326: 560-561.